Test technology to improve cervical cancer screening and diagnosis
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 49 years old
- Your most recent cervical screening test was positive or abnormal (like HPV, VIA, or abnormal cells on a Pap-type test)
- You still have your cervix (it was not removed)
- You are not pregnant, have a negative pregnancy test within 14 days of joining, and you are not breastfeeding
- You can and agree to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of microscope that can take high-quality pictures of cervical tissue samples right in the clinic during a biopsy or LEEP procedure. It may help doctors see the tissue more clearly and quickly, without needing to send it to a lab.
This study is testing a new, non-invasive way to screen for cervical cancer using light-based detection and epigenetic analysis. It may help find high-risk changes earlier and more accurately than current methods.
This trial is looking at better ways to diagnose changes in the cervix in women after menopause. It may help by improving how doctors decide which cervical abnormalities need attention and follow-up.
This study tests a new questionnaire that may help doctors better identify which women need treatment for cervical changes. It is for women who have had an abnormal Pap smear or a positive HPV test and are going for a colposcopy (a closer look at the cervix).
This study tests whether special light-based scans (optical spectroscopy) can help detect cervical cancer. It may be done around colposcopy, and participants may also be monitored with follow-up Pap smears after treatment.
This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.